vs
Side-by-side financial comparison of ASIA PACIFIC WIRE & CABLE CORP LTD (APWC) and Embecta Corp. (EMBC). Click either name above to swap in a different company.
Embecta Corp. is the larger business by last-quarter revenue ($261.2M vs $225.3M, roughly 1.2× ASIA PACIFIC WIRE & CABLE CORP LTD).
Disney Networks Group Asia Pacific was a Hong Kong–based commercial broadcasting company operating multiple specialty television channels. The company was founded in 1991 by Hong Kong - Canadian businessman Richard Li.
Embecta Corp. is a global medical technology company focused on diabetes care solutions. It designs, manufactures and distributes a full portfolio of products including insulin pen needles, syringes, infusion set components and related delivery devices, serving patients, healthcare providers and biopharmaceutical partners across North America, Europe, Asia Pacific and other major markets.
APWC vs EMBC — Head-to-Head
Income Statement — Q2 FY2022 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $225.3M | $261.2M |
| Net Profit | — | $44.1M |
| Gross Margin | 7.9% | 61.9% |
| Operating Margin | 2.2% | 31.9% |
| Net Margin | — | 16.9% |
| Revenue YoY | — | -0.3% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $0.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $261.2M | ||
| Q3 25 | — | $264.0M | ||
| Q2 25 | — | $295.5M | ||
| Q1 25 | — | $259.0M | ||
| Q4 24 | — | $261.9M | ||
| Q3 24 | — | $286.1M | ||
| Q2 24 | — | $272.5M | ||
| Q1 24 | — | $287.2M |
| Q4 25 | — | $44.1M | ||
| Q3 25 | — | $26.4M | ||
| Q2 25 | — | $45.5M | ||
| Q1 25 | — | $23.5M | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $14.6M | ||
| Q2 24 | — | $14.7M | ||
| Q1 24 | — | $28.9M |
| Q4 25 | — | 61.9% | ||
| Q3 25 | — | 60.0% | ||
| Q2 25 | — | 66.7% | ||
| Q1 25 | — | 63.4% | ||
| Q4 24 | — | 60.0% | ||
| Q3 24 | — | 60.7% | ||
| Q2 24 | — | 69.8% | ||
| Q1 24 | — | 64.6% |
| Q4 25 | — | 31.9% | ||
| Q3 25 | — | 21.4% | ||
| Q2 25 | — | 31.8% | ||
| Q1 25 | — | 24.3% | ||
| Q4 24 | — | 11.0% | ||
| Q3 24 | — | 9.2% | ||
| Q2 24 | — | 20.5% | ||
| Q1 24 | — | 13.6% |
| Q4 25 | — | 16.9% | ||
| Q3 25 | — | 10.0% | ||
| Q2 25 | — | 15.4% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.1% | ||
| Q2 24 | — | 5.4% | ||
| Q1 24 | — | 10.1% |
| Q4 25 | — | $0.74 | ||
| Q3 25 | — | $0.44 | ||
| Q2 25 | — | $0.78 | ||
| Q1 25 | — | $0.40 | ||
| Q4 24 | — | $0.00 | ||
| Q3 24 | — | $0.24 | ||
| Q2 24 | — | $0.25 | ||
| Q1 24 | — | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $201.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $-613.1M |
| Total Assets | — | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $201.3M | ||
| Q3 25 | — | $225.5M | ||
| Q2 25 | — | $230.6M | ||
| Q1 25 | — | $209.3M | ||
| Q4 24 | — | $210.0M | ||
| Q3 24 | — | $267.5M | ||
| Q2 24 | — | $275.1M | ||
| Q1 24 | — | $299.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $-613.1M | ||
| Q3 25 | — | $-650.6M | ||
| Q2 25 | — | $-669.6M | ||
| Q1 25 | — | $-736.2M | ||
| Q4 24 | — | $-768.8M | ||
| Q3 24 | — | $-738.3M | ||
| Q2 24 | — | $-763.7M | ||
| Q1 24 | — | $-769.6M |
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $17.2M |
| Free Cash FlowOCF − Capex | — | $16.6M |
| FCF MarginFCF / Revenue | — | 6.4% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | 0.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | $205.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $17.2M | ||
| Q3 25 | — | $84.0M | ||
| Q2 25 | — | $81.2M | ||
| Q1 25 | — | $31.8M | ||
| Q4 24 | — | $-5.3M | ||
| Q3 24 | — | $26.6M | ||
| Q2 24 | — | $-2.1M | ||
| Q1 24 | — | $24.3M |
| Q4 25 | — | $16.6M | ||
| Q3 25 | — | $76.7M | ||
| Q2 25 | — | $80.8M | ||
| Q1 25 | — | $31.7M | ||
| Q4 24 | — | $-6.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-11.8M | ||
| Q1 24 | — | $20.9M |
| Q4 25 | — | 6.4% | ||
| Q3 25 | — | 29.1% | ||
| Q2 25 | — | 27.3% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | -2.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -4.3% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 3.6% | ||
| Q1 24 | — | 1.2% |
| Q4 25 | — | 0.39× | ||
| Q3 25 | — | 3.18× | ||
| Q2 25 | — | 1.78× | ||
| Q1 25 | — | 1.35× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | -0.14× | ||
| Q1 24 | — | 0.84× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APWC
Segment breakdown not available.
EMBC
| Pen Needles | $185.5M | 71% |
| Safety | $37.3M | 14% |
| Syringes | $30.7M | 12% |
| Manufacturing Facility | $4.1M | 2% |
